MedPath

Stance

Stance 0.63% Stannous Fluoride Concentrate Rinse Tropical Breeze

Approved
Approval ID

3ae8badf-f960-62fd-e054-00144ff8d46c

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 23, 2025

Manufacturers
FDA

Elevate Oral Care

DUNS: 002863526

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

0.63% Stannous Fluoride Concentrate Rinse

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code57511-0202
Application NumberM021
Product Classification
M
Marketing Category
C200263
G
Generic Name
0.63% Stannous Fluoride Concentrate Rinse
Product Specifications
Route of AdministrationTOPICAL
Effective DateSeptember 23, 2025
FDA Product Classification

INGREDIENTS (3)

GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
STANNOUS FLUORIDEActive
Quantity: 1.2 mg in 1 mL
Code: 3FTR44B32Q
Classification: ACTIM

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 2/3/2015

Primary PACKAGE LABEL.

PRINCIPAL DISPLAY PANEL

Primary Package Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 9/23/2025

Uses

Indications

Uses

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 2/3/2015

Active Ingredients

Active Ingredients

WARNINGS SECTION

LOINC: 34071-1Updated: 9/23/2025

Warnings

Warnings

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 9/23/2025

Keep Out of Reach of Children

Keep Out of Reach of Children

INSTRUCTIONS FOR USE SECTION

LOINC: 59845-8Updated: 9/23/2025

Directions

Instructions for Use

Directions

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 9/23/2025

Inactive Ingredients

Inactive Ingredients

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 9/23/2025

Questions

Questions

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/31/2018

Dosage and Administration

Dosage and Administration

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 1/31/2018

Purpose

Purpose

OTHER SAFETY INFORMATION

LOINC: 60561-8Updated: 9/23/2025

Other Information

Other Information

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Stance - FDA Drug Approval Details